Ocular Therapeutix (OCUL) Misses Q3 EPS by 1c

Ocular Therapeutix (NASDAQ: OCUL) reported Q3 EPS of ($0.54), $0.01 worse than the analyst estimate of ($0.53). Revenue for the quarter came in at $523 thousand versus the consensus estimate of $510 thousand.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

You May Also Be Interested In

• Science Applications Int'l (SAIC) Tops Q2 EPS by 70c
• Danske Bank A/S (DANSKE:DC) (DNKEY) PT Raised to DKK436 at Morgan Stanley
• GameStop posts higher income despite revenue drop in Q2 2026